Name: Retatrutide 40mg
Brand: Pure Health
Price: 1450.00 AED
Availability: InStock

AED 1,450.00

Retatrutide is a cutting-edge, synthetic triple hormone receptor agonist. Known as the "Triple G," it targets three vital metabolic pathways: the GLP-1 (Glucagon-like peptide-1), GIP (Glucose-dependent insulinotropic polypeptide), and GCG (Glucagon) receptors.

GLP-1 (Glucagon-like Peptide-1) Receptor Agonist: Focuses on insulin secretion, glucose-dependent insulin sensitivity, and suppressing appetite via the brain's reward centers.
GIP (Glucose-dependent Insulinotropic Polypeptide) Receptor Agonist: Works synergistically with GLP-1 to improve lipid (fat) metabolism and further stabilize blood sugar levels.
GCG (Glucagon) Receptor Agonist: The "third" component that sets Retatrutide apart. It targets the liver and adipose tissue to increase energy expenditure (thermogenesis) and promote the breakdown of stored fats.

Week 1: 2.5mg
Week 2: 5mg
Week 3: 5mg
Week 4: 7.5mg
Maintenance: 10mg

Retatrutide is designed for once-weekly administration, meaning a single injection provides continuous therapeutic coverage for an entire week.

If you follow that exact 4-week progression, you will consume a total of 20mg in the first month.

This means a single 40mg vial will last you exactly two months if you stay at the 10mg maintenance dose thereafter, or slightly longer if you titrate slowly.

Store in fridge, Do No Freeze.
Keep pen capped and clean.

Individuals with a Personal or Family History of Medullary Thyroid Carcinoma (MTC)
Individuals with Pancreatitis
Individuals with Severe Gastrointestinal Disease
Pregnancy and Breastfeeding
Individuals with Severe Kidney or Liver Impairment

These side effects are typically temporary and decrease in frequency and severity over time as the body adjusts to the medication.

Nausea: Very common, often occurring immediately after the injection or during mealtime.
Vomiting: Can occur, particularly if meals are consumed too quickly or are excessively fatty.
Diarrhea or Constipation: Changes in bowel habits are frequent.
Abdominal Pain: Discomfort or cramping in the stomach area.

Retatrutide - 40mg

Retatrutide is an investigational compound and is not currently approved by major regulatory bodies (such as the FDA or EMA) for clinical use outside of authorized research trials. This product is a highly potent peptide and should be handled and administered with extreme caution.